Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 1Multiple Myeloma 1Lymphoproliferative Disorders 1Lymphoma, Mantle-Cell 1Lung Neoplasms 1Inflammation 1Fatigue 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Exercise 112Surveys and Questionnaires 56Early Intervention, Educational 49Standard of Care 46Methods 46Magnetic Resonance Spectroscopy 45Blood Specimen Collection 44Acupuncture Therapy 44Educational Status 43Radiotherapy 36Mammography 36Control Groups 31Therapeutics 29Counseling 29Psychiatric Rehabilitation 27Cyclophosphamide 27Sentinel Lymph Node Biopsy 25Biopsy 24Yoga 20Mastectomy, Segmental 20Resistance Training 19Palliative Care 18Neoadjuvant Therapy 18High-Energy Shock Waves 18Doxorubicin 18Cognitive Behavioral Therapy 18Magnetic Resonance Imaging 17Practice Guidelines as Topic 16Paclitaxel 16Trastuzumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms × Chromatin Immunoprecipitation Sequencing × Clear all
NCT07291414 2026-01-21

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

University of Michigan Rogel Cancer Center

Phase NA Recruiting
80 enrolled
BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡